AndreaBozzo/ceres-open-data-index huggingface dataset:
National Survey of Substance Abuse Treatment Services (N-SSATS-2007)

<p>The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, to update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), to analyze general treatment services trends, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment<br />
Facility Locator <a href="http://findtreatment.samhsa.gov">http://findtreatment.samhsa.gov</a>. Data are collected on topics including facility operation, services offered (assessment and pre-treatment, pharmacotherapies, testing, transitional, ancillary), detoxification, primary focus (substance abuse, mental health, both, general health, and other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, counseling and therapeutic approaches, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.</p>
Patent AT-E401184-T1: [Translated] INJECTION MOLDING TOOL FOR THE PRODUCTION OF DISK-SHAPED INFORMATION CARRIERS

An injection molding tool (10) for producing disc shaped moldings comprises primary and secondary plates (11,12) arranged opposite each other, which can move relative to each other to open and close the mould, and a mould ring (20). The latter surrounds the primary plate concentrically, closes off the injection mould (25) at the outer edge, and can move relative to the primary plate.  An injection molding tool (10) for producing disc shaped moldings, especially in the form of information carriers such as CD's and/or DVD's, comprises primary and secondary plates (11,12) arranged opposite each other, which can move relative to each other to open and close the mould, and a mould ring (20). The latter surrounds the primary plate concentrically, closes off the injection mould (25) at the outer edge, and can move relative to the primary plate. A tempering arrangement (26) for the mould ring is located in the ring, and tempering can be carried out electrically or by use of a tempering medium. The tempering arrangement is in the form of a channel, and a tempering medium can be supplied to it via a connection. A second arrangement (28) is used to blow the finished molding over its peripheral region after the mould has been opened.
Compound 529870: 2-(2-Furfuryl)-5-methylpyrazine

Chemical compound data from PubChem database. IUPAC Name: 2-(furan-2-ylmethyl)-5-methylpyrazine. Molecular Formula: C10H10N2O. Molecular Weight: 174.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Adult Mental Health Tables (Standard Errors and P values) - 1.1 to 1.64

These are the detailed tables pertaining to adult mental health from the 2010 National Survey on Drug Use and Health (NSDUH). These detailed tables present standard errors for totals and prevalence estimates of past year any mental illness (AMI), serious mental illness (SMI), suicidal thoughts and behavior, major depressive episode (MDE), treatment for depression (among adults with MDE), mental health service utilization, and measuers related to the co-occurrence of mental disorders with substance use or with substance use disorders. Results are provided for age group, gender, race/ethnicity, education level, employment status, poverty level, geographic area, insurance status. Comparisons are made between 2010 and 2002 to 2009.
Pemetrexed

Pemetrexed is a prescription chemotherapy drug used to treat certain cancers, like non-small cell lung cancer and malignant pleural mesothelioma. It works by blocking folate metabolism in cancer cells. Given intravenously as a solution in vials of 100mg, 500mg, or 1g, it's manufactured by Teva Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
TEDS Substance Abuse Treatment Admissions by Primary Substance of Abuse, According to Sex, Age Group, Race, and Ethnicity Tables 2014

This a Treatment Episode Data Set (TEDS) data table displaying substance abuse treatment admissions by primary substance abuse, according to sex, age group, race, and ethnicity. The Treatment Episode Data Set (TEDS) is a national data system of annual admissions to substance abuse treatment facilities. TEDS received treatment admission records from 46 states, the District of Columbia, and Puerto Rico in 2014.
Patent AT-E400152-T1: [Translated] APPARATUS AND METHOD FOR REMOVAL OF A PACKET HEADDER IN A RADIO COMMUNICATIONS SYSTEM

Embodiments relate to a method, system and network element, e.g. portable terminal, connectable to another network element. One of selectable modes is used for communication. A network element is adapted to perform a mode selection procedure for selecting the same mode for bidirectional communication between the network elements. The mode selection ensures the use of the same mode e.g. in uplink and downlink direction and thus enables e.g. IP telephony in UMTS using SIP protocol.  Embodiments may e.g. facilitate a VoIP communication session by way of a radio link with a mobile station.
State Cancer Profiles Web site

<p>The State Cancer Profiles (SCP) web site provides statistics to help guide and prioritize cancer control activities at the state and local levels.  SCP is a collaborative effort using local and national level cancer data from  the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR)  and National Cancer Institute's Surveillance, Epidemiology and End Results Registries (SEER).  SCP address select types of cancer and select behavioral risk factors for which there are evidence-based control interventions. The site provides incidence, mortality and prevalence comparison tables as well as interactive graphs and maps and support data.  The graphs and maps provide visual support for deciding where to focus cancer control efforts.</p>
Compound 529942: Dodecane, 6-methyl-5-propyl

Chemical compound data from PubChem database. IUPAC Name: 6-methyl-5-propyldodecane. Molecular Formula: C16H34. Molecular Weight: 226.44. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400730-T1: [Translated] DOSING DEVICE AND COMBUSTION ENGINE WITH DOSING DEVICE

The dosing device has a cooling system whose cooling circuit (115) is designed with its first part at least partially underneath the cooling device and its second part at least partially above a point heating the cooling circuit, more particularly above the injector module. INDEPENDENT CLAIM describes internal combustion engine with dosing device (100) where first part of cooling circuit is underneath the cooling device (120) and/or a second part is above a point heating the cooling circuit. Baffle plates are provided to direct the drive wind to the cooling device and/or to screen same from air heated by the engine.
Phentermine hydrochloride

Phentermine Hydrochloride is a prescription medication used to suppress appetite and aid in weight management for adults with obesity. It comes as 37.5 mg oral capsules and is a controlled substance (Schedule CIV). This generic version is approved under ANDA205017 by NUVO PHARM and manufactured by SUNRISE PHARMACEUTICAL, INC. This information was generated using AI and is provided for informational and research purposes only.
Compound 525050: 3'-Chloro,4'-methylpelargoanilide

Chemical compound data from PubChem database. IUPAC Name: N-(3-chloro-4-methylphenyl)nonanamide. Molecular Formula: C16H24ClNO. Molecular Weight: 281.82. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Program Instruction (PI-82-07)

This Program Instruction (PI) provides FY 1982 allotments for Title VI-B and procedures for applying for: 1) A State's share of funds available under Title IV-B in FY 1982 2) reallotted Title IV-B funds; and 3) funds to be transferred from Title IV-A or Title IV-E foster care.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527744: 3-Methyl-1,5-cyclooctadiene

Chemical compound data from PubChem database. IUPAC Name: 3-methylcycloocta-1,5-diene. Molecular Formula: C9H14. Molecular Weight: 122.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527809: Benzoic acid, 2-chloro, dodecyl ester

Chemical compound data from PubChem database. IUPAC Name: dodecyl 2-chlorobenzoate. Molecular Formula: C19H29ClO2. Molecular Weight: 324.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401358-T1: [Translated] TRANSPARENT POLYURETHANE HYDROGEL COMPOSITION, METHOD FOR PRODUCING TRANSPARENT POLYURETHANE HYDROGEL COMPOSITION AND USE AS AIR PRESENTATIVE

A transparent polyurethane-hydrogel composition includes a reaction product in aqueous solvent of a prepolymer and a water-soluble crosslinker in the substantial absence of organic solvent, and such a composition can be prepared by admixing a prepolymer and a water-soluble crosslinker in aqueous solvent and in the substantial absence of organic solvent. A prepolymer is present in an amount of no greater than about 5 weight percent based on total weight of all hydrogel components. The prepolymer is generally prepared from at least one water-soluble polyol and an isocyanate. A water-soluble crosslinker generally has a crosslinker functionality of at least 2 and is selected to provide a site ratio of initial isocyanate to crosslinker (i.e., moles NCOxfunctionality/moles crosslinkerxfunctionality) of at least about 1.5 and no greater than about 2.6. In one embodiment, a crosslinker is effective to react with and solubilize residual isocyanate concurrently with the reaction between prepolymer and crosslinker. A transparent polyurethane-hydrogel composition has desirable gel physical properties and is useful for an air-freshener application.
National Child Abuse and Neglect Data System (NCANDS)

The NCANDS is a federally-sponsored national data collection effort created for the purpose of tracking the volume and nature of child maltreatment reporting each year within the United States.

<b>Units of Response: </b>Report-Child Combination

<b>Type of Data: </b>Administrative

<b>Tribal Data: </b>Unavailable

<b>Periodicity: </b>Annual

<b>Demographic Indicators: </b>Disability;Ethnicity;Housing Status;Military;Race;Sex

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>https://www.ndacan.acf.hhs.gov/datasets/request-restricted-data.cfm

<b>Data Use Agreement Location: </b>https://www.ndacan.acf.hhs.gov/datasets/order_forms/termsofuseagreement.pdf

<b>Granularity: </b>Individual;State

<b>Spatial: </b>United States

<b>Geocoding: </b>FIPS Code;State
Compound 529195: Benzenamine, 2-methyl, mono-TMS

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-N-trimethylsilylaniline. Molecular Formula: C10H17NSi. Molecular Weight: 179.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Debate: PCI vs CABG: a moving target, but we are gaining

The treatment of patients with coronary artery disease continues to evolve; all three strategies – medical therapy, surgical revascularization, and percutaneous coronary intervention – have changed. Medical therapy with intense risk-factor modification and treatment with a statin, aspirin, and angiotensin-converting enzyme (ACE) inhibitors, should be used unless contraindicated. Surgical therapy has also changed with the introduction of minimally invasive, beating heart surgery. Percutaneous coronary intervention has perhaps changed the most radically with adjunctive therapy – glycoprotein IIb/IIIa inhibitors, thienopyridines, and reliance on stent implantation. The future, with new distal protection devices and drug-coated stents, should continue to see increased numbers of patients who can benefit from percutaneous intervention.
Tennessee (TN)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Tennessee overall and for substate regions within Tennessee. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Comparison of complete nuclear receptor sets from the human,

Background
          The availability of complete genome sequences enables all the members of a gene family to be identified without limitations imposed by temporal, spatial or quantitative aspects of mRNA expression. Using the nearly completed human genome sequence, we combined in silico and experimental approaches to define the complete human nuclear receptor (NR) set. This information was used to carry out a comparative genomic study of the NR superfamily.
        
        
          Results
          Our analysis of the human genome identified two novel NR sequences. Both these contained stop codons within the coding regions, indicating that both are pseudogenes. One (HNF4 γ-related) contained no introns and expressed no detectable mRNA, whereas the other (FXR-related) produced mRNA at relatively high levels in testis. If translated, the latter is predicted to encode a short, non-functional protein. Our analysis indicates that there are fewer than 50 functional human NRs, dramatically fewer than in Caenorhabditis elegans and about twice as many as in Drosophila. Using the complete human NR set we made comparisons with the NR sets of C. elegans and Drosophila. Searches for the >200 NRs unique to C. elegans revealed no human homologs. The comparative analysis also revealed a Drosophila member of NR subfamily NR3, confirming an ancient metazoan origin for this subfamily.
        
        
          Conclusions
          This work provides the basis for new insights into the evolution and functional relationships of NR superfamily members.
Patent AT-E400711-T1: [Translated] MULTI-LAYER MATERIAL, ESPECIALLY FOR USE AS A SUB-ROOF

A water vapour permeable laminate (16), especially for use as underroofing or underslating for roofs. The laminate comprises an outer layer (18) that is formed by a perforated first film or foil, and an inner layer (19) which has at least some areas formed by a second, non-perforated film of the type having a water vapour diffusion resistance, which varies in dependency of the relative humidity of air in contact therewith. Thus, the vapour diffusion resistance is reduced, when the relative humidity increases, and vice versa, and the laminate is characterised in that the water vapour diffusion resistance of the outer layer (18) substantially exceeds the maximum water vapour resistance of the second film (19).
Compound 525663: N-(4-Bromobenzylidene)-p-toluidine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-(4-methylphenyl)methanimine. Molecular Formula: C14H12BrN. Molecular Weight: 274.15. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527017: alpha-Methyl isobutanoyl fentanyl

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide. Molecular Formula: C24H32N2O. Molecular Weight: 364.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?

Thrombolysis and primary angioplasty are both recommended reperfusion strategies for elderly patients presenting with myocardial infarction (MI). Primary angioplasty is most beneficial in high-risk patients. While the elderly have a high absolute risk of dying or developing complications after MI, they also have an increased risk of intracranial haemorrhage if they are given thrombolytic therapy. It could therefore be reasonably argued that primary angioplasty is the reperfusion strategy of choice in the elderly. However, primary angioplasty has not been shown to have a greater relative benefit than thrombolytic therapy in the elderly. Recent data from the Fibrinolytic Therapy Trialists' (FTT) Collaborative Group show that thrombolytic therapy significantly reduces mortality compared with control treatment in patients over 75 years of age presenting within 12 h of symptom onset, with ST-segment elevation or bundle branch block. Future advances in adjunctive therapies may improve myocyte perfusion and hence the outcomes achieved by both invasive and noninvasive reperfusion strategies. Better thrombolytic regimens incorporating adjunctive agents such as bivalirudin may reduce the risk of intracranial haemorrhage. Few hospitals can provide a 24-h primary angioplasty service with door-to-balloon times consistently less than 90 min, and thrombolytic therapy is therefore a far more practical option in most instances.
Compound 529163: 1-Hexanol, 6-amino, TBDMS

Chemical compound data from PubChem database. IUPAC Name: N-[tert-butyl(dimethyl)silyl]-6-[tert-butyl(dimethyl)silyl]oxyhexan-1-amine. Molecular Formula: C18H43NOSi2. Molecular Weight: 345.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526624: Bis(2-methyl-3-furyl)disulfide

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-[(2-methylfuran-3-yl)disulfanyl]furan. Molecular Formula: C10H10O2S2. Molecular Weight: 226.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530131: 6-Thiohypoxanthine, TMS

Chemical compound data from PubChem database. IUPAC Name: 6-trimethylsilyloxypurine-8-thione. Molecular Formula: C8H10N4OSSi. Molecular Weight: 238.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Novel mutations in the

Background
          Breast cancer is the most common female malignancy and a major cause of death in middle-aged women. So far, germline mutations in the BRCA1 and BRCA2 genes in patients with early-onset breast and/or ovarian cancer have not been identified within the Iranian population.
        
        
          Methods
          With the collaboration of two main centres for cancer in Iran, we obtained clinical information, family history and peripheral blood from 83 women under the age of 45 with early-onset breast cancer for scanning of germline mutations in the BRCA1 and BRCA2 genes. We analysed BRCA1 exons 11 and BRCA2 exons 10 and 11 by the protein truncation test, and BRCA1 exons 2, 3, 5, 13 and 20 and BRCA2 exons 9, 17, 18 and 23 with the single-strand conformation polymorphism assay on genomic DNA amplified by polymerase chain reaction.
        
        
          Results
          Ten sequence variants were identified: five frameshifts (putative mutations – four novel); three missense changes of unknown significance and two polymorphisms, one seen commonly in both Iranian and British populations.
        
        
          Conclusions
          Identification of these novel mutations suggests that any given population should develop a mutation database for its programme of breast cancer screening. The pattern of mutations seen in the BRCA genes seems not to differ from other populations studied. Early-onset breast cancer (less than 45 years) and a limited family history is sufficient to justify mutation screening with a detection rate of over 25% in this group, whereas sporadic early-onset breast cancer (detection rate less than 5%) is unlikely to be cost-effective.
Epoprostenol

Epoprostenol Sodium is a prescription injectable drug administered intravenously to dilate blood vessels, often used for conditions like pulmonary hypertension. It comes as a lyophilized powder in vials with strengths of 0.5 mg or 1.5 mg, manufactured by Sun Pharmaceutical Industries, Inc. under ANDA210473. This information was generated using AI and is provided for informational and research purposes only.
Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 2 - New York

Rate of deaths by age/gender (per 100,000 population) for motor vehicle occupants killed in crashes, 2012 & 2014. 2012 Source: Fatality Analysis Reporting System (FARS). 2014 Source: National Highway Traffic Safety Administration's (NHTSA) Fatality Analysis Reporting System (FARS), 2014 Annual Report File Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
Patent AT-E400940-T1: [Translated] NETWORK MANAGEMENT CENTRALIZATION ALARM BOX AND ALARM PROCESSING METHOD

A network management concentrated alarm box and the alarm processing method thereof. The present invention provides a network management concentrated alarm box and the alarm processing method thereof, which is easy to implement, cooperates closely with the NMS, delivers automatic handshaking function, and can detect online (or offline) of the alarm box and recover to alarm state after the connection recovers from interruption. Wherein a network management concentrated alarm box comprises: An alarm background module designed to receive all alarm message frames from the NMS and forward the alarm message frames to the alarm box interface module; An alarm box interface module designed to convert the received alarm message frames into alarm message frames in the communication protocol of the alarm box, send the alarm message frames to the alarm box via a serial interface, receive operation commands from the alarm box foreground, and control the alarm box accordingly; An alarm box designed to process the alarm message frames by type in a concentrated manner. <IMAGE>